Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Joseph O Humtsoe

3PUBLICATIONS
8CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 25, 2026
Potent Anti-Tumor Activity of the AXL-Targeted Antibody-Drug Conjugate, Mipasetamab Uzoptirine (ADCT-601), in Preclinical Models of Adenoid Cystic Carcinoma.

|May 05, 2026
Potent anti-tumor activity of the AXL-targeted antibody-drug conjugate, mipasetamab uzoptirine (ADCT-601), in preclinical models of adenoid cystic carcinoma.

|Jul 17, 2025
The Small Molecule Inhibitor of the Wnt-β-Catenin Pathway, CWP232291, Inhibits Tumor Growth in Preclinical Models of Salivary Gland Adenoid Cystic Carcinoma.

Joseph O Humtsoe, Bhumsuk Keam, Hyun-Su Kim

Pageof 1

Frequent Collaborators

3 joint publications

Leilani Jones

3 joint publications

Patrick K Ha

2 joint publications

Anita Pothukuchi

2 joint publications

Karina Chen

2 joint publications

Shorook Na'ara

2 joint publications

Hyunseok Kang

1 joint publications

Bhumsuk Keam

1 joint publications

Susan Lee

Frequent Collaborators

3 joint publications

Leilani Jones

3 joint publications

Patrick K Ha

2 joint publications

Anita Pothukuchi

2 joint publications

Karina Chen